Clinical Trials · NCT01732068
Treatment of Poor Ovarian Responders With Corifollitropin Alfa Followed by hpHMG in a Short GnRH Agonist Protocol
- Phase
- Phase 2
- Recruitment status
- Completed
- Sponsor
- Universitair Ziekenhuis Brussel
- Enrollment
- 51
- Start date
- Jul 2012
- Locations
- 1 site, Belgium
- Primary endpoint
- Ongoing pregnancy rate